Coverage
-
November 19, 2021
A California federal judge has dismissed a proposed class action from investors in Sorrento Therapeutics Inc. who claimed the company misled the public about its COVID-19 treatment, finding the investors didn't adequately show how the company's statements were misleading.
4 other articles on this case.
View all »